BridgeMD
New treatment option for Diabetes Type 1
Official title Diabetes Intervention Involving Person-centred Nutritional Education
ClinicalTrials.gov ID: NCT07258758
What this study is testing
- What it's testing
- The overall objective for this project is to evaluate the effects of a person-centred education intervention to promote a healthy, sustainable Nordic diet compared with the current practice of providing short dietary information on health outcomes of adults with Type 1 diabetes. The study will measure the intervention's impact on blood glucose levels, blood lipids, blood pressure, and adherence to a sustainable and healthy Nordic diet.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Type 1 Diabetes.
- Diabetes duration for more than 12 months at screening.
- Adults 18 years or older.
- HbA1c more than 57mmol/mol.
- Use of continuous glucose monitoring (CGM) sensor for more than three months at screening and during the study period.
You likely can't join if
- Women of childbearing potential: ongoing pregnancy or planned pregnancy during the study period.
- Cognitive impairment or other disease that study physician find non-compatible with participation.
- Planned change in glucose lowering treatment during study period (change of mealtime insulin analogue with same pharmacodynamic profile allowed).
- Planned change of CGM sensor during the study.
- Food allergies or intolerances that are incompatible with adhering to Nordic nutrition recommendations.
- Current or planned treatment with corticosteroids during the study (other than for replacement therapy).
See the full eligibility criteria
- Type 1 Diabetes.
- Diabetes duration for more than 12 months at screening.
- Adults 18 years or older.
- HbA1c more than 57mmol/mol.
- Use of continuous glucose monitoring (CGM) sensor for more than three months at screening and during the study period.
- Use of basal and bolus insulin regimen for more than three months at screening and during the study period.
- Written Informed Consent.
- Women of childbearing potential: ongoing pregnancy or planned pregnancy during the study period.
- Cognitive impairment or other disease that study physician find non-compatible with participation.
- Planned change in glucose lowering treatment during study period (change of mealtime insulin analogue with same pharmacodynamic profile allowed).
- Planned change of CGM sensor during the study.
- Food allergies or intolerances that are incompatible with adhering to Nordic nutrition recommendations.
- Current or planned treatment with corticosteroids during the study (other than for replacement therapy).
The study team makes the final eligibility decision.
Where it's taking place
- Enköping, Uppland, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Enköping, Uppland, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.